What is HER2?

Aaronson, 1991, Growth factors and cancer, Science, 254, 1146, 10.1126/science.1659742 Agnantis, 1986, Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancer, Oncology, 43, 36, 10.1159/000226101 Akiyama, 1986, The product of the human c- erb B-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity, Science, 232, 1644, 10.1126/science.3012781 Akiyama, 1988, Tumor promoter and epidermal growth factor stimulate phosphorylation of the c- erb B-2 gene product in MKN-7 human adenocarcinoma cells, Molecular Cellular Biology, 8, 1019, 10.1128/MCB.8.3.1019 Alroy, 1997, The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through ligand-receptor combinatorial interactions, FEBS Letters, 410, 83, 10.1016/S0014-5793(97)00412-2 Barnes, 1992, Overexpression of the c- erb B-2 oncogene: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance, European Journal of Cancer, 28, 644, 10.1016/S0959-8049(05)80117-0 Benz, 1992, Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu, Breast Cancer Research and Treatment, 24, 85, 10.1007/BF01961241 Berns, 1992, Prevalence of amplification of the oncogenes c -myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors, European Journal of Cancer, 28, 697, 10.1016/S0959-8049(05)80129-7 Chazin, 1992, Transformation mediated by the human HER-2 gene independent of epidermal growth factor receptor, Oncogene, 7, 1859 Chong, 1999, Quantitation of EGFR and c- erb B-2 expression in preinvasive compared to invasive breast cancer, European Journal of Cancer, 35, S201, 10.1016/S0959-8049(99)81219-2 Chong, 1999, Quantitation of c- erb B-2 in primary breast cancer allows identification of a further poor prognostic group, European Journal of Cancer, 35, S89, 10.1016/S0959-8049(99)80725-4 Connelly, 1990, The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade, Proceedings of the National Academy of Sciences USA, 87, 6054, 10.1073/pnas.87.16.6054 Cossman, 1991, p53 in the diagnosis of human neoplasia, Journal of the National Cancer Institute, 83, 980, 10.1093/jnci/83.14.980 Coussens, 1985, Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene, Science, 230, 1132, 10.1126/science.2999974 DiAusgustine, 1997, EGF-related peptides and their receptors in mammary gland development, Journal of Mammary Gland Biology and Neoplasia, 2, 109, 10.1023/A:1026395513038 Di Fiore, 1987, Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells, Cell, 51, 1063, 10.1016/0092-8674(87)90592-7 Di Fiore, 1987, erb B-2 is a potent oncogene when overexpressed in NIH/3T3 cells, Science, 237, 178, 10.1126/science.2885917 Escot, 1986, Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas, Proceedings of the National Academy of Sciences USA, 83, 4834, 10.1073/pnas.83.13.4834 Graus-Porta, 1997, ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalling, EMBO Journal, 16, 1647, 10.1093/emboj/16.7.1647 Halter, 1992, Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations, American Journal of Pathology, 140, 1131 Harris, 1992, Breast cancer, New England Journal of Medicine, 327, 473, 10.1056/NEJM199208133270706 Hortobagyi, 1999, Recent developments in breast cancer therapy, Seminars in Oncology, 26, 11 Hudziak, 1987, Increased expression of the putative growth factor receptor p185HER2causes transformation and tumorigenesis of NIH 3T3 cells, Proceedings of the National Academy of Sciences USA, 84, 7159, 10.1073/pnas.84.20.7159 Hynes, 1994, The biology of erbB -2/neu/HER -2 and its role in cancer, Biochimica et Biophysica Acta, 1198, 165 Kim, 1998, The interactive effect of ras, HER2, p53 and bcl-2 expression in predicting the survival of non-small cell lung cancer patients, Lung Cancer, 22, 181, 10.1016/S0169-5002(98)00086-5 Kokai, 1989, Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts, Cell, 58, 287, 10.1016/0092-8674(89)90843-X Kovach, 1991, Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinoma, Journal of the National Cancer Institute, 83, 1004, 10.1093/jnci/83.14.1004 Lei, 1995, Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival, International Journal of Pancreatology, 17, 15, 10.1007/BF02788354 Lemmon, 1994, Regulation of signal transduction and signal diversity by receptor oligomerization, Trends in Biochemical Science, 19, 459, 10.1016/0968-0004(94)90130-9 Lewis, 1993, Proceedings of the American Association of Cancer Research, 34, 523 Lidereau, 1988, Amplification of the int-2 gene in primary human breast tumours, Oncogene Research, 2, 285 Liu, 1992, The HER2 (c- erb B-2) oncogene is frequently amplified in in situ carcinomas of the breast, Oncogene, 7, 1027 McKenzie, 1989, Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185, Oncogene, 4, 543 Marchionni, 1993, Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system, Nature, 362, 312, 10.1038/362312a0 Mark, 1999, HER2 status: implications for patients, Eur J Oncol Nursing, 4 Marte, 1995, Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells, Molecular Endocrinology, 9, 14 Normanno, 1997, EGF-related peptides in the pathophysiology of the mammary gland, Journal of Mammary Gland Biology and Neoplasia, 2, 143, 10.1023/A:1026351730785 Orr-Urtreger, 1993, Neural expression and chromosomal mapping of Neu differentiation factor to 8 pp12–21, Proceedings of the National Academy of Sciences USA, 90, 1867, 10.1073/pnas.90.5.1867 Pauletti, 1996, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization, Oncogene, 13, 63 Peles, 1992, Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells, Cell, 69, 205, 10.1016/0092-8674(92)90131-U Pinkas-Kramarski, 1997, Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation, Oncogene, 15, 2803, 10.1038/sj.onc.1201466 Plowman, 1993, Heregulin induces tyrosine phosphorylation of HER4/p180 erb B4, Nature, 366, 473, 10.1038/366473a0 Press, 1990, Expression of the HER2/neu proto-oncogene in normal adult and fetal tissues, Oncogene, 5, 953 Riviere, 1991, Comparative investigation of c- erb B2/neu expression in head and neck tumors and mammary cancer, Cancer, 67, 2142, 10.1002/1097-0142(19910415)67:8<2142::AID-CNCR2820670823>3.0.CO;2-8 Sarup, 1991, Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor functions and inhibits tumor cell growth, Growth Regulation, 1, 72 Schroeder, 1998, Dynamic expression and activation of ErbB receptors in the developing mouse mammary gland, Cell Growth and Differentiation, 9, 451 Schroeder, 1997, Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer, Anticancer Research, 17, 2799 Shi, 1992, Overexpression of the c- erb B-2/neu- encoded p185 protein in primary lung cancer, Molecular Carcinogenesis, 5, 213, 10.1002/mc.2940050308 Slamon, 1987, Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene, Science, 235, 177, 10.1126/science.3798106 Slamon, 1989, Studies of the HER-2/neu protooncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Sliwkowski, 1994, Coexpression of erb B2 and erb B3 proteins reconstitutes a high affinity receptor for heregulin, Journal of Biological Chemistry, 269, 14661, 10.1016/S0021-9258(17)36676-0 van der Geer, 1994, Receptor protein-tyrosine kinases and their signal transduction pathways, Annual Reviews in Cell Biology, 10, 251, 10.1146/annurev.cb.10.110194.001343 Vennstrom, 1982, Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus, Cell, 28, 135, 10.1016/0092-8674(82)90383-X Venter, 1987, Overexpression of the c- erb B-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification, Lancet, 2, 69, 10.1016/S0140-6736(87)92736-X Weiner, 1990, Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung, Cancer Research, 50, 421